UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

When prospective randomised trials have unexpected results: where do we go from there?

BJOG : an international journal of obstetrics and gynaecology, 2019-07, Vol.126 (8), p.960-960

Duska, LR

2019

Link zum Volltext

Verfügbarkeit prüfen

Surgery is critical to a multidisciplinary approach to ovarian cancer

BJOG : an international journal of obstetrics and gynaecology, 2018-09, Vol.125 (10), p.1253-1253

Duska, LR

2018

Link zum Volltext

Verfügbarkeit prüfen

Recognising endometrial cancer in pre‐menopausal women

BJOG : an international journal of obstetrics and gynaecology, 2017-02, Vol.124 (3), p.412-412

Duska, LR

2017

Link zum Volltext

Verfügbarkeit prüfen

Stuck in the middle: diagnostic and clinical management challenges surrounding CIN2

BJOG : an international journal of obstetrics and gynaecology, 2020-05, Vol.127 (6), p.737-737

2020

Link zum Volltext

Verfügbarkeit prüfen

Granulosa cell tumours of the ovary: the challenges of studying a rare tumour

BJOG : an international journal of obstetrics and gynaecology, 2017-01, Vol.124 (1), p.149-149

Duska, LR

2017

Link zum Volltext

Verfügbarkeit prüfen

PET trumps surgical staging in locally advanced cervical cancer

BJOG : an international journal of obstetrics and gynaecology, 2017-06, Vol.124 (7), p.1095-1095

2017

Link zum Volltext

Verfügbarkeit prüfen

Continuous epidural infusion anesthesia and analgesia in gynecologic oncology patients: Less pain, more gain?

Gynecologic oncology, 2015-01, Vol.136 (1), p.77-81

2015

Link zum Volltext

Verfügbarkeit prüfen

Endometrial Cancer in Women 40 Years Old or Younger

Gynecologic oncology, 2001-11, Vol.83 (2), p.388-393

2001

Link zum Volltext

Verfügbarkeit prüfen

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

Cancer, 2000-10, Vol.89 (7), p.1532-1540

2000

Link zum Volltext

Verfügbarkeit prüfen

Fertility-sparing surgery for ovarian low malignant potential tumors

Gynecologic oncology, 2005-08, Vol.98 (2), p.263-266

2005

Link zum Volltext

Verfügbarkeit prüfen

Combination photoimmunotherapy and cisplatin : Effects on human ovarian cancer ex vivo

JNCI : Journal of the National Cancer Institute, 1999-09, Vol.91 (18), p.1557-1563

1999

Link zum Volltext

Verfügbarkeit prüfen

Surgical staging of ovarian low malignant potential tumors

Obstetrics and gynecology (New York. 1953), 2004-08, Vol.104 (2), p.261-266

2004

Link zum Volltext

Verfügbarkeit prüfen

The Role of Cytoreductive Surgery in the Management of Stage IV Uterine Papillary Serous Carcinoma

Gynecologic oncology, 2001-04, Vol.81 (1), p.92-99

2001

Link zum Volltext

Verfügbarkeit prüfen

Epithelial ovarian carcinoma in the reproductive age group

Cancer, 1999-06, Vol.85 (12), p.2623-2629

1999

Link zum Volltext

Verfügbarkeit prüfen

Treatment of uterine papillary serous carcinoma with platinum‐based chemotherapy and paclitaxel

International journal of gynecological cancer, 2006-02, Vol.16 (S1), p.267-272

2006

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel and Platinum Chemotherapy for Malignant Mixed Mullerian Tumors of the Ovary

Gynecologic oncology, 2002-06, Vol.85 (3), p.459-463

2002

Link zum Volltext

Verfügbarkeit prüfen

Loss of cables, a cyclin-dependent kinase regulatory protein, is associated with the development of endometrial hyperplasia and endometrial cancer

Cancer research (Chicago, Ill.), 2004, Vol.64 (1), p.202-208

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of anastrozole in women with asymptomatic müllerian cancer

Gynecologic oncology, 2003-12, Vol.91 (3), p.596-602

2003

Link zum Volltext

Verfügbarkeit prüfen

Clinical Evaluation of Atypical Glandular Cells of Undetermined Significance on Cervical Cytology

Obstetrics and gynecology (New York. 1953), 1998-02, Vol.91 (2), p.278-282

1998

Link zum Volltext

Verfügbarkeit prüfen

Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma

Gynecologic oncology, 2003-12, Vol.91 (3), p.558-562

2003

Link zum Volltext

Verfügbarkeit prüfen

A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with “high-risk” endometrial cancer

Gynecologic oncology, 2005, Vol.96 (1), p.198-203

2005

Link zum Volltext

Verfügbarkeit prüfen

Endocervical Curettage at Conization to Predict Residual Cervical Adenocarcinoma in Situ

Gynecologic oncology, 2002-10, Vol.87 (1), p.129-132

2002

Link zum Volltext

Verfügbarkeit prüfen

Cytokines IL‐1β, IL‐2, IL‐6, IL‐8, MCP‐1, GM‐CSF and TNFα in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel

International journal of gynecological cancer, 2000-01, Vol.10 (1), p.33-41

2000

Link zum Volltext

Verfügbarkeit prüfen

Stage IIB–IVB Cervical Adenocarcinoma: Prognostic Factors and Survival

Gynecologic oncology, 2002-01, Vol.84 (1), p.115-119

2002

Link zum Volltext

Verfügbarkeit prüfen

Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy

Obstetrics and gynecology (New York. 1953), 2005-05, Vol.105 (5), p.1006-1011

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

When prospective randomised trials have unexpected results: where do we go from there?

Surgery is critical to a multidisciplinary approach to ovarian cancer

Recognising endometrial cancer in pre‐menopausal women

Stuck in the middle: diagnostic and clinical management challenges surrounding CIN2

Granulosa cell tumours of the ovary: the challenges of studying a rare tumour

PET trumps surgical staging in locally advanced cervical cancer

Continuous epidural infusion anesthesia and analgesia in gynecologic oncology patients: Less pain, more gain?

Endometrial Cancer in Women 40 Years Old or Younger

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

Fertility-sparing surgery for ovarian low malignant potential tumors

Combination photoimmunotherapy and cisplatin : Effects on human ovarian cancer ex vivo

Surgical staging of ovarian low malignant potential tumors

The Role of Cytoreductive Surgery in the Management of Stage IV Uterine Papillary Serous Carcinoma

Epithelial ovarian carcinoma in the reproductive age group

Treatment of uterine papillary serous carcinoma with platinum‐based chemotherapy and paclitaxel

Paclitaxel and Platinum Chemotherapy for Malignant Mixed Mullerian Tumors of the Ovary

Loss of cables, a cyclin-dependent kinase regulatory protein, is associated with the development of endometrial hyperplasia and endometrial cancer

Phase II trial of anastrozole in women with asymptomatic müllerian cancer

Clinical Evaluation of Atypical Glandular Cells of Undetermined Significance on Cervical Cytology

Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma

A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with “high-risk” endometrial cancer

Endocervical Curettage at Conization to Predict Residual Cervical Adenocarcinoma in Situ

Cytokines IL‐1β, IL‐2, IL‐6, IL‐8, MCP‐1, GM‐CSF and TNFα in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel

Stage IIB–IVB Cervical Adenocarcinoma: Prognostic Factors and Survival

Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy

Suchergebnisse filtern